<?xml version="1.0" encoding="UTF-8"?>
<p>In 2009, President Obama traveled to Cairo where he spoke out about engaging scientists in the Muslim world and extending a hand in science diplomacy 
 <xref rid="pntd.0002808-Koenig1" ref-type="bibr">[53]</xref>. Despite the establishment of a valuable US Science Envoy program, to date such activities have not led to substantive joint vaccine partnerships despite the observation that several Islamic countries in the Middle East and Asia, including Egypt, Indonesia, Iran, and Saudi Arabia, have some capacity for vaccine product development 
 <xref rid="pntd.0002808-Hotez8" ref-type="bibr">[23]</xref>. With an Iranian scientist from the Tehran University of Medical Sciences, Dr. Mohammed Rokni, I recently advocated launching such efforts between the US and Iran and provided as an example the opportunity for developing a vaccine for leishmaniasis, which has devastated areas of conflict in the Middle East and North Africa 
 <xref rid="pntd.0002808-Hotez11" ref-type="bibr">[54]</xref>. Similar opportunities exist in order to partner with nations such as Cuba, which has considerable technical expertise both in producing and delivering vaccine 
 <xref rid="pntd.0002808-Andrus2" ref-type="bibr">[55]</xref>, and possibly even countries such as North Korea, which has some technical capabilities 
 <xref rid="pntd.0002808-Hotez12" ref-type="bibr">[56]</xref>.
</p>
